Women Must Get Abortion Pill in Person: US Supreme Court
Similar in-person rules for other medications have been suspended during the pandemic
Miscellaneous Ob/Gyn Conditions
MPR Weekly Dose Podcast Episode 53
This week: encouraging news on antibody therapies; EUA guidelines for potential vaccines; Remdesivir distribution; The HIV drug that failed to have an impact; And the preterm birth treatment the FDA want withdrawn from the market.
FDA Proposes Makena Be Withdrawn From the Market
Makena received accelerated approval in 2011 to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth.
Modafinil in Early Pregnancy Not Tied to Congenital Malformations
Large birth registry study conducted in Norway and Sweden did not show link to major malformations
Pap/HPV Cotesting Better for Cervical Cancer Screening in Over 30s
Nondetection rate is 13.1% for cotesting, higher when testing is done >12 months prediagnosis.
Clinically Meaningful Pain Reduction Observed With Relugolix in Endometriosis Trial
Positive topline results were announced from the phase 3 SPIRIT 1 study investigating relugolix (Myovant Sciences), in combination with estradiol and norethindrone acetate, in women with pain associated with endometriosis.
Newborn Respiratory Distress Up With Maternal Antidepressant Use
Moderate, high sustained prenatal antidepressant use associated with increased risk for preterm birth.
Benzodiazepine Use Linked to Risk for Ectopic Pregnancy
Excess of 80 ectopic pregnancies per 10,000 pregnancies found in women with benzodiazepine prescription.
Live Biotherapeutic Promising for Prevention of Bacterial Vaginosis
Following vaginal metronidazole for BV, incidence of recurrence lower with Lactin-V versus placebo.
Low Doses of Bevacizumab Tested for Retinopathy of Prematurity
Phase 1 study suggests that intravitreous injection of 0.004mg may be lowest effective dose.
